Publications by authors named "Jennifer Snaith"

Claim this Profile
A
Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches.
Jennifer R Snaith, Phoom Narongkiatikhun, Petter Bjornstad, Jerry R Greenfield, Kalie L Tommerdahl

Diabetes Care· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial.
Jennifer R Snaith, Ruth Frampton, Dorit Samocha-Bonet, Jerry R Greenfield

Diabetes Care· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of metformin on insulin resistance in adults with type 1 diabetes: a 26-week randomized double-blind clinical trial.
Jennifer R Snaith, Nick Olsen, Jennifer Evans, Greg M Kowalski, Clinton R Bruce

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence from euglycaemic-hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections-Post hoc meta-analysis.
Andrzej S Januszewski, Jennifer R Snaith, Agata Grzelka-Wozniak, Johan R A Simonsen, Nirupa Sachithanandan

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology.
Ruth Frampton, Samantha Hocking, Jennifer R Snaith, Jerry R Greenfield

Trends Endocrinol Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.
Viral N Shah, Rikke M Agesen, Lars Bardtrum, Erik Christiansen, Jennifer Snaith

J Diabetes Sci Technol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cardioprotective Adjuncts in Type 1 Diabetes.
Jerry R Greenfield, Ruth Frampton, Kellie Millard, Jennifer R Snaith

Diabetes Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial.
Ruth Frampton, Jennifer R Snaith, Samantha Hocking, Jane Holmes-Walker, Nicholas Olsen

Diabet Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 Diabetes.
Bella D Lamaro, Jerry R Greenfield, Jennifer R Snaith

J Patient Exp· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing patterns of adjunctive therapy for the treatment of type 1 diabetes mellitus among Australian endocrinologists.
Patrice Forner, Jennifer Snaith, Jerry R Greenfield

Intern Med J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Semaglutide in Adolescents with Obesity.
Jennifer R Snaith, Jerry R Greenfield

N Engl J Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?
Jennifer R Snaith, Jerry R Greenfield

Med J Aust· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes.
Jennifer R Snaith, Mark Danta, Jerry R Greenfield

Lancet Gastroenterol Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial.
Jennifer R Snaith, Dorit Samocha-Bonet, Jennifer Evans, Zhixin Liu, Greg Kowalski

Diabet Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technologies in the management of type 1 diabetes.
Jennifer R Snaith, D Jane Holmes-Walker

Med J Aust· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomy.
Jennifer R Snaith, Duncan McLeod, Arthur Richardson, David Chipps

Endocrinol Diabetes Metab Case Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor: "Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry".
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield

J Clin Endocrinol Metab· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin.
Thaw D Htet, Anastasia Godneva, Zhixin Liu, Eliza Chalmers, Dmitry Kolobkov, Jennifer R Snaith

BMJ Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: it's changed us.
Jennifer R Snaith, Jerry R Greenfield

Intern Med J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive adrenal hyperplasia from paraneoplastic adrenocorticotropic hormone.
Jennifer R Snaith, Bo Gao, David Chipps, Christian M Girgis

BMJ Case Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield

Trends Endocrinol Metab· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nesidioblastosis following laparoscopic sleeve gastrectomy.
Albert Kim, Jennifer R Snaith, Hema Mahajan, Deborah Jane Holmes-Walker

Clin Endocrinol (Oxf)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664.
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield

Diabetes Care· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess mortality and cardiovascular disease risk in type 1 diabetes.
Jennifer R Snaith, Deborah J Holmes-Walker, Christian M Girgis, Jerry R Greenfield

Lancet· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes.
Cecilia Chi, Jennifer Snaith, Jenny E Gunton

Heart Lung Circ· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis